Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 32 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Stromal CCL2/CXCL10/SPARC axes drive pro-tumor CHI3L1 expression for microenvironmental modulation in pancreatic cancer progression and therapeutic innovation
    Pei-Chia Su, Yan-Shen Shan, Ya-Chin Hou +3
    Journal of Biomedical SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  2. CD83 CAR T provides an alternative strategy to CD19-targeting in B cell malignancies
    Brian Christopher Betts, Constanza Savid-Frontera, Shannon McSain +13
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMCDOAJ
  3. CBFB-MYH11 directly activates TGFβ and PD-L1 to drive immune evasion in acute myeloid leukemia
    Hui Fang, Chang Liu, Xiaocui Lu +16
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  4. Disparities in Cancer Incidence and Mortality in Rural Versus Urban Michigan
    Reba Dhillon, Stephanie Mackenzie, Austin H. Qasawa +6
    Cancer MedicinePeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  5. LncRNA MALAT1 Targets METTL3 to Orchestrate INPP5B/LRIG2 Signaling and Promote Non‐Small Cell Lung Cancer Progression
    Shuhong Tian, Fayu Ling, Dunzhi Fu +3
    Chemical Biology & Drug DesignPeer-reviewedCC BY 4.0Full textOncologyPMC
  6. Tip60‐Mediated USP22 Lactylation Drives Glutamine Metabolic Reprogramming via SLC25A5 in TNBC
    Fang Zhen, Hongyi Wang, Ningzhi Zhang +5
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  7. Circulating tumor cells in lobular versus ductal metastatic breast cancer
    Emily M. Dolce, Elizabeth P. Darga, Nicholas C. Henderson +8
    Breast Cancer Research and TreatmentPeer-reviewedCC BY 4.0Full textOncologyPMC
  8. Linking clinical border morphology to cell-scale growth mechanisms in melanoma: a segmentation-to-simulation alignment study
    C. Liu, L. Zu
    bioRxivPreprintCC BYFull textOncologybioRxiv
  9. Cancer Incidence, Healthcare Access, and Support Resource Distribution in Delaware : A Statewide Epidemiological Analysis, 2018-2022.
    Ryan Stephens, Katherine Smith
    Delaware journal of public healthPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  10. A serum proteomics‐based predictive model for steroid‐resistant immune checkpoint inhibitor associated myocarditis
    Yerui Zhang, Yihan Li, Jian Zhang +9
    Clinical and Translational MedicinePeer-reviewedCC BYFull textOncologyDOAJ
  11. MTAP Orchestrates Stemenss and 5-Fluorouracil Resistance in Liver Cancer via PRMT5/SOX2 Signaling
    ZHANG Yu-Bo, FANG Zhao-Xiong, LI Yun +3
    Shengwu huaxue yu shengwu wuli jinzhanPeer-reviewedCC BY-NCFull textOncologyDOAJ
  12. Systematic Review and Descriptive Synthesis of Behaviour Change Techniques in Physical Activity Interventions During and Beyond Breast Cancer
    Alejandro Dominguez Garcia, Barbara A. Mullan, Kylie Hill +2
    Lifestyle MedicinePeer-reviewedCC BYFull textOncologyDOAJ
  13. CLDN18.2 in pancreatic ductal adenocarcinoma: Biomarker assessment, spatial heterogeneity and therapeutic modality selection
    Ruyu Tan, Zhexin Zhang, Jiaxin Wang +3
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textOncologyDOAJ
  14. Stability‐guided transition modelling reveals an Active‐to‐Evasive immune ecosystem continuum in cervical cancer
    Chia‐Hung Chen, Tzu‐Hsiang Weng, Hui‐Ju Kao +5
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textOncologyDOAJ
  15. Cathepsin L in cancer: Context‐dependent functions, microenvironmental regulation and translational opportunities
    Yujun Wu, Qin Huang, Zixuan Ding +5
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textOncologyDOAJ
  16. Ovarian cancer during pregnancy: Pregnancy‐adjusted inflammatory and haematologic signatures for earlier risk recognition and clinical decision‐making
    Emmanuel Ifeanyi Obeagu
    Clinical and Translational DiscoveryPeer-reviewedCC BYFull textOncologyDOAJ
  17. Association between the prognostic nutritional index and cognitive impairment in patients with heart failure: a cross-sectional study
    Chengyang Li, Yingxuan Gao, Qi Niu +4
    Frontiers in NutritionPeer-reviewedCC BYFull textOncologyDOAJ
  18. Antibody-drug conjugates therapy for triple-negative breast cancer: a systematic review and meta-analysis
    Ke Wan, Ke Wan, Mengxin Liu +1
    Frontiers in MedicinePeer-reviewedCC BYFull textOncologyDOAJ
  19. Hepatic small vessel neoplasm, a first case report in a liver transplant recipient
    Afaf Awad Y. Ahmad, Michael Craughwell, Lindsey Clarke +3
    Frontiers in GastroenterologyPeer-reviewedCC BYFull textOncologyDOAJ
  20. Systematic analysis of genetic vulnerabilities caused by chromosome loss events in cancer
    Y. Bei, J. Keane, M. Lynch +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  21. Targeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy
    Renata Ramalho-Oliveira, Douglas V. Faget, Radhika Mishra +7
    bioRxivPreprintCC BYFull textOncologybioRxivPMC
  22. Response to SMAC mimetics in patient-derived models of triple-negative breast cancer relies on RIPK1 activation
    Elisabeth Brown, Paige Jensen, Chieh-Hsiang Yang +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  23. Transient Splicing-Associated Isoform Remodeling Defines Early MAPKi Resistance Adaptation in Melanoma
    Sumit Mukherjee, Arashdeep Singh, Sumeet Patiyal +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  24. Spatially enforced engagement of PD-1⁺ T cells with AXL⁺ cells reprograms the tumor microenvironment and overcomes anti-PD-1 resistance
    K. M. Yegodayev, G. Perelman, T. Shami +34
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. Choline Kinase Alpha Inhibition is a Mutation Agnostic Therapeutic Vulnerability in Clonal Hematopoiesis
    B. J. Gheller, O. Mitchell, M. Quach +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC